Inflammation | Page 43 of 58

Inflammatory Disease :: Array BioPharma’s MEK Inhibitor, ARRY-438162, meets initial clinical objectives

Array BioPharma Inc. (Nasdaq: ARRY) announced that its first-in-class MEK inhibitor for the treatment of inflammatory diseases, ARRY-438162, has met its primary objectives in a single ascending dose clinical study involving 20 healthy volunteers. These results were presented by Array?s President and Chief Scientific Officer, Kevin Koch, Ph.D., at the 14th International Inflammation Research Association Conference in Cambridge, Maryland.

Heart Disease :: Dilated cardiomyopathy – child heart disease due to inflammation

Researchers have uncovered partial causes for dilated cardiomyopathy, a form of potentially fatal child heart disease that often goes undetected. DCM means the heart fails to pump properly and the condition can often lead to heart failure. The US research, published in the Journal of the American Medical Association, found heart inflammation is the most common cause.

Diet :: Apples and apple juice – quercetin antioxidant good for neurological health

For those who think that picking and eating apples this time of year is just for fun and for the great taste of America’s favorite fruit, you may want to think again. Apples and apple juice may be among the best foods that anyone could add to their diet, finds a collection of recent research studies, the latest of which was presented yesterday at the Society of Neuroscience annual conference in Atlanta. Researchers G. Bureau and M. Martinoli from the University of Quebec a Trois-Rivieres, found that quercetin (one of the antioxidants found abundantly in apples) was one of two compounds that helped to reduce cellular death that is caused by oxidation and inflammation of neurons.

Alzheimer’s Disease :: Marijuana like compound – WIN may slow Alzheimer’s disease, memory loss

A new U.S. study finds that marijuana may help slow the progression of Alzheimer’s disease. Researchers from Ohio State University in Columbus found that marijuana may contain compounds that can slow memory loss associated with Alzheimer’s disease.

Cancer :: Taxotere, docetaxel by Sanofi-Aventis for Advanced Head and Neck Cancer

The Food and Drug Administration (FDA) approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN). This disease represents approximately 3 percent of all new cancer cases in the United States.

Allergy :: Food allergies could be fought with friendly bacteria in alcoholic milkshake

Feeding babies alcoholic milk may help to protect against some food allergies. Kefir, a traditional fermented drink, is consumed in Eastern Europe as a health food, and is often used to wean babies, as it is easily digested. Food allergy prevalence is especially high in children under the age of three, with around 5-8% of infants at risk. Currently the only treatment is avoidance of the problematic food.

Psoriasis :: Psoriasis associated with increased risk for heart attack

Adults with psoriasis, especially younger patients with severe psoriasis, appear to be at increased risk for a heart attack, according to a study in the October 11 issue of JAMA.

Health :: Hostile men have poorer lung function

Men with short fuses may also be short of breath linking hostile temperament to poorer lung function.

Schizophrenia :: Solvay pharmaceuticals and Wyeth – new drug for bifeprunox to treat schizophrenia

Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) for bifeprunox, an investigational atypical antipsychotic for the treatment of schizophrenia.

Alzheimer’s Disease :: Mediterranean diet lowers alzheimer’s risk

If you follow a Mediterranean diet your chances of developing Alzheimer’s disease could be 68% lower than people who don’t, say researchers from Columbia University Medical Center, New York. You can read about this study in the journal Archives of Neurology, October issue.